Risk estimation from somatic mutation assays

Mutation Research - Reviews in Genetic Toxicology

Volumn 365, Issue 1-3, 1996, Pages 107-117

  Heddle, John A ^a   Swiger, Roy R ^a  

^a YORK UNIVERSITY   (Canada)

Author keywords

cancer; Dlb 1; lacI; lacZ; mutation spectrum

Indexed keywords

CARCINOGEN; ENVIRONMENTAL CHEMICAL; MUTAGENIC AGENT;

ANIMAL EXPERIMENT; CANCER RISK; CARCINOGENESIS; HUMAN; MOUSE; MUTATION RATE; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SOMATIC MUTATION;

ANIMALIA;

EID: 0030250608     PISSN: 01651110     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1110(96)90015-9     Document Type: Article

References (70)

1. Aaltonen L.A., Peltomaki P., Leach F.S., Sistonen P., Rylkkanen L., Mecklin J.P., Jarvinen H., Powell S.M., Jen J., Hamilton S.R., Peterson G.M., Kinzler K.W., Vogelstein B., de la Chapelle A. Clues to the pathogenesis of familial colorectal cancer. Science. 260:1993;812-816.
2. Bodmer W., Bishop T., Karran P. Genetic steps in colorectal cancer. Nature Genet. 6:1994;217-219.
3. Bohr V.A., Smith C.A., Okumoto D.S., Hanawalt P.C. DNA repair in an active gene: removal of pyrimidine dimers from the DHFR gene of CHO cells is much more efficient than in the genome overall. Cell. 40:1985;359-369.
4. Burkhart J.G., Winn R.N., VanBeneden R., Malling H.V. The ØX174 bacteriophage shuttle vector for the study of mutagenesis. Environ. Mol. Mutagen. 19:(Suppl. 20):1992;8.
5. Carr G.J., Gorelick N.J. Statistical tests of significance in transgenic mutation assays: considerations on the experimental unit. Environ. Mol. Mutagen. 24:1994;276-282.
6. Carr G.J., Gorelick N.J. Statistical design and analysis of mutation studies in transgenic mice. Environ. Mol. Mutagen. 25:1995;246-255.
7. Cavenee W.K., Dryja T.P., Phillips R.A., Benedict W.F., Godbout R., Gallie B.L., Murphree A.L., Strong L.C., White R.L. Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature. 305:1983;779-784.
8. Dean B.J., Senner K. Detection of chemically induced somatic mutation in Chinese hamsters. Mutation Res. 46:1977;403-407.
9. Doll R., Peto R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J. Natl. Cancer Inst. 66:1981;1191-1308.
10. Douglas G.R., Gingerich J.D., Gossen J.A., Barlett S.A. Sequence spectra of spontaneous lacZ mutations in transgenic mouse somatic and germline tissues. Mutagenesis. 9:1994;451-458.
11. Douglas G.R., Jiao J., Gingerich J.D., Gossen J.A., Soper L.M. Temporal and molecular characteristics of mutations induced by ethynitrosourea in germ cells isolated from seminiferous tubules and in spermatozoa of lacZ transgenic mice. Proc. Natl. Acad. Sci. USA. 92:1995;7485-7489.
12. du Manoir S., Speicher M.R., Joos S., Schrock E., Popp S., Dohner H., Kovacs G., Robert-Nicoud M., Lichter P., Cremer T. Detection of complete and partial chromosome gains and losses by comparative genomic in situ hybridization. Hum. Genet. 90:1993;590-610.
13. Eshleman J.R., Lang E.Z., Bowerfind G.K., Parsons R., Vogelstein B., Willson J.K., Viegl M.L., Sedwick W.D., Markowitz S.D. Increased mutation rate at the hprt locus accompanies microsatellite instability in colon cancer. Oncogene. 10:1995;33-37.
14. Felton J.S., Knize M.G. Heterocyclic-amine mutagens/carcinogens in foods. Cooper C.S., Grover P.L. Handbook of Experimental Pharmacology. Vol. 94/I:1990;471-502 Spring-Verlag, Berlin.
15. Festing M.F. Genetic variation in outbred rats and mice and its implications for toxicological screening. J. Exp. Anim. Sci. 35:1993;210-220.
16. Finette B.A., Sullivan L.M., O'Neill J.P., Nicklas J.A., Vacek P.M., Albertini R.J. Determination of hprt mutant frequencies in T-lymphocytes from a healthy pediatric population: statistical comparison between newborn, children and adult mutant frequencies, cloning efficiency and age. Mutation Res. 308:1994;223-231.
17. Fishel R., Lescoe M.K., Rao M.R., Copeland N.G., Jenkins N.A., Garber J., Kane M., Kolodner R. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell. 75:1993;1027-1038.
18. Froggatt N.J., Leveson S.H., Garner R.C. Low frequency and late occurrence of p53 and dcc aberrations in colorectal tumours. J. Cancer Res. Clin. Oncol. 121:1995;7-15.
19. Goldsworthy T.L., Recio L., Brown K., Donehower L.A., Mirsalis J.C., Tennant R.W., Purchase I.F.H. Transgenic animals in toxicology. Fundamental and Appl. Toxicol. 22:1994;8-19.
20. Gossen J.A., de Leeuw W.J.F., Tan C.H.T., Lohman P.M.H., Berends F., Knook D.L., Zwarthoff E.C., Vijg J. Efficient rescue of integrated shuttle vectors from transgenic mice: a model for studying mutations in vivo. Proc. Natl. Acad. Sci. USA. 86:1989;7981-7985.
21. Gossen J.A., de Leeuw W.J.F., Verwest A., Lohman P.H.M., Vijg J. High somatic mutation frequencies in a LacZ transgene integrated on the mouse X-chromosome. Mutation Res. 250:1991;423-429.
22. Gossen J.A., Martus H.J., Wei J.Y., Vijg J. Spontaneous and X-ray-induced deletion mutations in a LacZ plasmid-based transgenic mouse model. Mutation Res. 331:1995;89-97.
23. Guttenplan J.B. Mutagenesis by N-nitroso compounds: relationships to DNA adducts, DNA repair and mutational spectra. Mutation Res. 223:1990;177-187.
24. Haenszel W., Berg J.W., Segi M., Kurihara M., Locke F.B. Large-bowel cancer in Hawaiian Japanese. J. Natl. Cancer Inst. 51:1973;1765-1779.
25. Hanawalt P.C. Transcription-coupled repair and human disease. Science. 266:1994;1957-1958.
26. Harris H. The Principles of Human Biochemical Genetics. 1975;473 + xiv North-Holland, Amsterdam.
27. Heddle J.A., Krepinsky A.B., Marshall R.R. Cellular sensitivity to mutagens and carcinogens in the chromosome breakage and other cancer prone syndromes. German J. Chromosome Mutation and Neoplasia. 1983;203-234 Alan R. Liss, New York.
28. Heddle J.A., Krepinsky A.B., Marshall R.R. Cellular sensitivity to mutagens and carcinogens in the chromosome breakage and other cancer prone syndromes. German J. Chromosome Mutation and Neoplasia. 1983;451 + xxxiii Alan R. Liss, New York.
29. Heddle J.A., Shaver-Walker P., Tao K.S., Zhang X.B. Treatment protocols for transgenic mutation assays in vivo. Mutagenesis. 11:(1):1995;. in press.
30. Ho L., Hanawalt P.C. Gene-specific DNA repair in terminally differentiating rat myoblasts. Mutation Res. 255:1991;123-141.
31. Hoorn A.J.W., Custer L.L., Myhr B.C., Brusick D., Gossen J., Vijg J. Detection of chemical mutagens using Muta™Mouse: a transgenic mouse model. Mutagenesis. 8:1993;7-10.
32. Ionov Y., Peinado M.A., Malkhosyan S., Shibata D., Percho M. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature. 363:1993;558-561.
33. Jones I.M., Burkhart-Shultz K., Carrano A.V. A method to quantify spontaneous and in vivo induced thioguanine-resistant mouse lymphocytes. Mutation Res. 147:1985;97-105.
34. Kohler S.W., Provost G.S., Fieck A., Kretz P.L., Bullock W.O., Sorge J.A., Putman D.L., Short J.M. Spectra of spontaneous and mutagen-induced mutations in the lacI gene in transgenic mice. Proc. Natl. Acad. Sci. USA. 88:1991;7962-7985.
35. Lasko D., Cavenee W. Loss of constitutional heterozygosity in human cancer. Annu. Rev. Genet. 25:1991;281-314.
36. Lave L.B., Omenn G.S. Cost-effectiveness of short-term tests for carcinogenicity. Nature. 324:1986;29-34.
37. Layton D.W., Bogen K.T., Knize M.G., Hatch F.T., Johnson M., Felton J.S. Cancer risk of heterocyclic amines in cooked foods: an analysis and implications for research. Carcinogenesis. 16:1995;30-52.
38. Lee A.T., DeSimoone C., Cerami A., Bucala R. Comparative analysis of DNA mutations in lacI transgenic mice with age. FASEB J. 8:1994;545-550.
39. Lidereau R., Nogues C. Genetics and cancer: application to the breast. Arch. Anat. Cytol. Pathol. 43:1995;5-11.
40. Loeb L.A. Mutator Phenotype may be required for multistage carcinogenesis. Cancer Res. 51:1991;3075-3079.
41. McCann J., Choi E., Yamasaki E., Ames B.N. Detection of carcinogens as mutagens in the Salmonella/microsome test: assay of 300 chemicals. Proc. Natl. Acad. Sci. USA. 72:1975;5135-5139.
42. Mellon I., Spivak G., Hanawalt P.C. Selective removal of transcription-blocking DNA damage from the transcribed strand of the mammalian DHFR gene. Cell. 51:1987;241-249.
43. Nacheva E., Grace C., Holloway T.L., Green A.R. Comparative genomic hybridization in acute myeloid leukemia. A comparison with G-banding and chromosome painting. Cancer Genet. Cytogenet. 82:1995;9-16.
44. Nowell P.C. The clonal evolution of tumor cell populations. Science. 194:1976;23-28.
45. O'Sullivan J.F., Schmidt G.H., Paul D., Winton D.J., Blount M.A., Ponder B. Spontaneous mutation rate. Nature. 352:1991;200-201.
46. Paashuis-Lew Y., Zhang X.B., Heddle J.A. Ex vivo mutants, mosaics and expression time in the lacI transgenic Big Blue™ mouse. Mutation Res. 1996;. submitted.
47. Parsons R., Li G.M., Longley M., Modrich P., Liu B., Hamilton S.R., Kinzler K.W., Vogelstein B. Mismatch repair deficiency in phenotypically normal human cells. Science. 268:1995;738-740.
48. Piegorsch W.W., Lockhart A.C., Margolin B.H., Tindall K.R., Gorelick N.J., Short J.M., Carr G.J., Thompson E.D., Shelby M.D. Sources of variability in data from a lacI transgenic mouse mutation assay. Environ. Mol. Mutagen. 23:1994;17-31.
49. Reitmair A.H., Schmits R., Ewel A., Bapat B., Redston M., Mitri A., Waterhouse P., Mittrucker H.-W, Wakeham A., Liu B., Tomason A., Griesser H., Gallinger S., Ballhausen W.G., Fishel R., Mak T.W. MSH2 deficient mice are viable and susceptible to lymphoid tumours. Nature Genet. 11:1995;64-70.
50. Rhyu M.G., Park W.S., Jung Y.J., Choi S.W., Meltzer S.J. Allelic deletions of MCC/APC and p53 frequent late events in human gastric carcinogenesis. Gastroenterology. 106:1994;1584-1588.
51. Richardson K.K., Richardson F.C., Crosby R.M., Swenberg J.A., Skopek T.R. DNA base changes and alkylation following in vivo exposure of Escherichia coli to N-methyl-N-nitrosourea or N-ethyl-N-nitrosourea . Proc. Natl. Acad. Sci. USA. 84:1987;344-348.
52. Russell L.B. The mouse spot test as a predictor of heritable genetic damage and other endpoints. de Serres F.J. Chemical Mutagens, Principles and Methods for Their Detection. Vol. 8:1983;95-110 Plenum Press, New York.
53. Russell L.B., Rinchuk E.M. Structural differences between specific-locus mutations induced by different exposure regimes in mouse spermatogonial stem cells. Mutation Res. 288:1993;187-195.
54. Salamone M.F., Mavournin K.H. Bone marrow micronucleus assay: a review of the mouse stocks and their published mean spontaneous micronucleus frequencies. Environ. Mol. Mutagen. 23:1994;239-270.
55. Shaver-Walker P.M., Urlando C., Tao K.S., Zhang X.B., Heddle J.A. Enhanced somatic mutation rates induced in stem cells by low chronic exposures. Proc. Natl. Acad. Sci. USA. 92:1995;11470-11474.
56. Shephard S.E., Lutz W.K., Schlatter C. The lacI transgenic mouse mutagenicity assay: quantitative evaluation in comparison to tests for carcinogenicity and cytogenetic damage in vivo. Mutation Res. 306:1994;119-128.
57. 1 mice exposed to N-ethyl-N-nitrosourea . Proc. Natl. Acad. Sci. USA. 89:1992;7866-7870.
58. Skopek T.R., Kort K.L., Marino D.R. Relative sensitivity of the endogenous hprt gene and the lacI transgene in ENU-treated Big Blue B6C3F1 mice. Environ. Mol. Mutagen. 26:1995;9-15.
59. Stephenson D.A., Searle A.G. The effects of X-rays on the induction of somatic mutations and growth in the retinal pigmented epithelium during development of the mouse eye. Mutagenesis. 1:1986;135-141.
60. Sugimura T., Sato S. Mutagens-carcinogens in foods. Cancer Res. 43:1983;2415s-2421s.
61. Tao K.S., Heddle J.A. The accumulation and persistence of somatic mutations. Mutagenesis. 9:1994;187-191.
62. Tao K.S., Urlando C., Heddle J.A. Comparison of somatic mutation in a transgenic versus host locus. Proc. Natl. Acad. Sci. USA. 90:1993;10681-10685.
63. Tennant R.W., Margolin B.H., Shelby M.D., Zeiger E., Haseman J.K., Spalding J., Caspary W., Resnick M., Stasiewicz S., Anderson B., Minor R. Prediction of chemical carcinogenicity in rodents from in vitro genetic toxicity assays. Science. 236:1987;933-941.
64. Thibodeau S.N., Bren G., Schaid D. Microsatellite instability in cancer of the proximal colon. Science. 260:1993;816-819.
65. Tucker J.D., Lee D.A., Ramsey M.J., Briner J., Olsen L., Moore D.H. On the frequency of chromosome exchanges in a control population measured by chromosome painting. Mutation Res. 313:1994;193-202.
66. Vomiero-Highton G., Heddle J.A. An assay for loss of heterozygosity in vivo at the Dlb-l locus. Mutagenesis. 10:1995;381-384.
67. Winton D.J., Blount M.A., Ponder B.A.J. A cloned marker induced by mutation in mouse intestinal epithelium. Nature. 333:1988;463-466.
68. Zhang X.B., Urlando C., Tao K.S., Heddle J.A. Factors affecting somatic mutation frequencies in vivo. Mutation Res. 338:1995;189-201.
69. Zhang X.B., Tao K.S., Urlando C., Shaver-Walker P., Heddle J.A. Mutation rates in the intestinal epithelium of mice on diets high or low in fat. Mutagenesis. 1996a;. in press.
70. Zhang X.B., Felton J., Tucker J.D., Urlando C., Heddle J.A. Intestinal mutagenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and amino[a]carboline (AaC) in transgenic mice. Carcinogenesis. 1996b;. in press.